Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 224-815-8 | CAS number: 4501-58-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Sensitisation data (human)
Administrative data
- Endpoint:
- sensitisation data (humans)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 11 September 1978 to 12 October 1978
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: A non-GLP study performed to sound scientific principles with a sufficient level of detail to assess the quality of the submitted data.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 978
- Report date:
- 1978
Materials and methods
- Type of sensitisation studied:
- skin
- Study type:
- study with volunteers
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: Maximization Test, 'Updating the Maximization Test for Identifying Contact Allergens' Contact Dermatitis 1975 1: 231-239
- Deviations:
- not specified
- GLP compliance:
- no
Test material
- Reference substance name:
- (R)-2,2,3-trimethylcyclopent-3-ene-1-acetaldehyde
- EC Number:
- 224-815-8
- EC Name:
- (R)-2,2,3-trimethylcyclopent-3-ene-1-acetaldehyde
- Cas Number:
- 4501-58-0
- Molecular formula:
- C10H16O
- IUPAC Name:
- (R)-2,2,3-trimethylcyclopent-3-ene-1-acetaldehyde
- Details on test material:
- - Name of test material: Campholenic aldehyde
Constituent 1
Method
- Type of population:
- general
- Ethical approval:
- not specified
- Subjects:
- - Number of subjects exposed: 25
- Sex: male and female
- Age: 19 to 50 years old
- Race: white, black and oriental
- Demographic information: no further data - Clinical history:
- All volunteers were reported to be healthy
- Route of administration:
- dermal
- Details on study design:
- PRE-TESTING
The test substance was pre-tested on twenty-five subjects to determine whether sodium lauryl sulfate pre-treatment was required. A patch of material was applied to a normal site on the volar forearm for 48 hours under occlusion. The material was found to be not irritating.
INDUCTION
0.3 g of test substance was applied under an occlusive dressing to the same site on the forearm for five 48 hour periods. Since the test substance was found to be non-irritating, it was decided to use 2.5% sodium lauryl sulfate during this period.
CHALLENGE
Following a ten day rest period, a challenge patch of the test substance was applied to a different site (opposite upper arm) for a 48 hour period under occlusion. The challenge site was pre-treated for one hour with 10% aqueous solution of sodium lauryl sulfate. Observations were made immediately after removal of the challenge patch and 24 hours thereafter based on the following scale:
0 - not sensitised
1 - mild sensitisation (mainly erythema and a little oedema)
2 - moderate sensitisation (erythema with infiltration, raised, spreading beyond the borders with or without vesiculation)
3 - strong sensitisation (large, vesiculo-bullous, vividly red, infiltrated plaques)
Results and discussion
- Results of examinations:
- There was one instance of contact-sensitisation from this material on the maximisation study.
Any other information on results incl. tables
Table 1: Results
Induction Application | Challenge | ||||||
Subject number | 1 | 2 | 3 | 4 | 5 | 48 h | 72 h |
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2 | 0 | 0 | 2 | * | * | * | * |
3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
17 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
21 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
22 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
23 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
* indicates subject stopped on study due to allergic reaction. The subject refused to have challenge done because of allergic reaction which appeared during induction
Applicant's summary and conclusion
- Conclusions:
- Under the conditions of the test, there was one instance of contact-sensitisation with the test substance. The test substance should be considered to be a weak sensitiser.
- Executive summary:
In a human sensitisation study conducted in line with Contact Dermatitis (1975) 1: 231-239, the test substance was considered to be a weak sensitiser in human volunteers.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
